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Introduction
Proteomics aims at a large-scale charac-
terization of localization, abundance,
post-translational modifications, and bio-
molecular interactions of the proteins in
an organism, with the goal of understand-
ing their function. An extensive insight can
be obtained by identifying and quantifying
the components of biological mixtures. For
example, a) In studies of biomolecular
networks, partners interacting with a
protein can help determine its function.
It is possible to experimentally isolate
protein complexes, e.g., using tag affinity
purification. Identification of the compo-
nents of this mixture helps determine
potential interactors [1]. b) Post-transla-
tional modifications such as phosphoryla-
tion play an important role in regulating
biological processes, e.g., cellular growth
and signaling. Identification and quantifi-
cation of phosphorylated proteins and
their substrates helps elucidate complex
signaling pathway phosphorylation events
[2]. c) Molecular biomarkers, i.e., proteins
for which changes in abundance are
indicative of an early onset of a disease
or a therapy response, are of interest in
clinical research. Identifying and quanti-
fying components of a biofluid such as
serum helps detect proteins with such
discriminative ability [3]. d) A goal of
genome annotation is the discovery and
validation of protein-coding regions. Iden-
tifying peptides and proteins in a cell helps
confirm and improve the annotations at
the translational level, e.g., by confirming
the presence of intron boundaries or
alternative splicings [4].
Mass spectrometry is a method of choice
for protein identification and quantifica-
tion due to its sensitivity and to the
versatility of the instrumentation [5,6]. A
typical ‘‘bottom-up’’ workflow experimen-
tally digests the proteins into a mixture of
peptides with an enzyme such as trypsin.
This is necessary, in part, because the
sensitivity of the mass spectrometer is
much higher for peptides than for pro-
teins. The peptides are then injected onto
a liquid chromatography (LC) column
from which they elute sequentially. The
eluted peptides are ionized and separated
by the mass spectrometer according to
their ratio of mass to charge (m/z)i na
mass spectrum (MS).
The collection of mass spectra obtained
at different elution times forms an LC-MS
run shown in Figure 1A. Peaks in the run
correspond to peptide ions; however, the
sequence of amino acids underlying each
peak is unknown. For identification, the
mass spectrometer isolates the biological
material from a peak (called precursor ion
in this context), and subjects it to a high-
collision energy. The energy breaks the
peptide at different amide bonds, and the
resulting fragments are separated accord-
ing to their m/z in a secondary spectrum
(called MS2, MS/MS, or tandem MS),
shown in Figure 1B. Distances between
peaks in the MS/MS spectrum are used to
infer the peptide sequence of the parent
LC-MS peak.
Peak intensity is related to the abun-
dances of peptides, and can be used for
relative quantification. With the label-free
approach, a separate LC-MS run is
obtained for each biological sample, and
peaks are quantified and compared across
runs. In stable isotopic labeling workflow,
samples from different groups are labeled
metabolically (e.g., in SILAC, where stable
isotopes are included in the growth
medium of an organism), or chemically
(e.g., in ICAT or iTRAQ, where reacting
chemical labels are applied after tryptic
digestion). Several samples (e.g., one from
each group) are then mixed, and their
peaks are identified and quantified within
the same run. Finally, a targeted workflow
based, for example, on selected reaction
monitoring (SRM) [7], increases sensitivity
and specificity by monitoring signals from
a list of predefined peptides.
The design of proteomic experiments,
and subsequent analysis of the spectra,
involves extensive computation and re-
quires expertise at the intersection of
computer science, engineering, and statis-
tics. It presents exciting opportunities for
both methodological and applied compu-
tational research.
Experimental Design
Experimental design specifies how bio-
logical samples are selected and allocated
in space and time during spectral acquisi-
tion. For example, a biomarker discovery
project can produce biased conclusions if
patients from different groups have differ-
ent characteristics (such as prior medica-
tion), or their spectra are acquired under
different conditions. Moreover, sample
selection and allocation can be inefficient,
and can undermine the ability to uncover
the true differences between groups.
Statistical experimental design avoids
bias and optimizes efficiency by using
replication, randomization, and blocking,
and by choosing an appropriate type and
number of replicates [8]. The need for a
statistical design of proteomic experiments
is increasingly emphasized [9]. Specific
choices require a statistical model that
describes the spectra, and development of
such models is an important area of
research.
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After spectral acquisition, the first
computational task is to extract and store
peak information. Unfortunately, most
mass spectrometer vendors have their
own proprietary formats. An advance has
been made by implementing open XML-
based formats (such as mzXML), and the
associated converters and validators, to
store this information and to make the
subsequent analysis vendor-neutral [10].
These tools are available from http://
www.proteomecommons.org. Efforts are
invested, for example, by the Proteomics
Standards Initiative (http://www.psidev.
info), in further developments of XML
formats.
Identification of Peptides and
Proteins
An MS/MS spectrum such as in
Figure 1A is generated by a series of
peptide fragments. Thus, mass differences
between neighboring MS/MS peaks are
used to determine the underlying amino
acid sequence. Typical approaches involve
searches of an a priori–defined database,
de novo identifications, and combinations
of the two [11]. Here we focus on the
database-based approach which compares
each observed spectrum against entries in
a database (Figure 2A). Several aspects of
the procedure require consideration.
Database of Candidate Peptides
Protein sequence databases now exist
for many organisms. One can digest the
sequences in silico into peptides, and
construct a theoretical spectrum for each
peptide. Alternatively, one can use a
library of peptides with associated consen-
sus experimental spectra derived from
previous identifications [12]. In both cases,
the number of candidate peptides increas-
es exponentially when we allow nonspe-
cific enzymes and/or post-translational
modifications (PTM) that alter a theoret-
ical mass.
Scoring Function
Scoring functions quantify the similarity
of a candidate peptide-spectrum match
(PSM). A typical two-stage procedure
filters out PSMs with incompatible peptide
and precursor ion masses, and scores
plausible PSMs using counts of shared
MS/MS peaks. Newer scores incorporate
additional characteristics, e.g., peak inten-
sity (for spectral libraries) and empi-
rical peptide detectability [13], and learn
the scores dynamically from the data
[14,15].
Search Algorithm
For each observed spectrum, the algo-
rithm scores its similarity to every candi-
date peptide and returns the best-scoring
PSM. Since typical experiments produce
hundreds of thousands of MS/MS spectra,
development of efficient search algorithms
is an active area of research. Improve-
ments include clustering the observed
spectra using a similarity metric, and only
searching the resulting consensus spectra
[16]. Another approach aligns the ob-
served spectra in a procedure similar to
genomic sequence alignment, and creates
meta-spectra that cover longer protein
segments [17]. Finally, a de novo identi-
fication of short sequence tags (e.g., three
amino acids long) combined with a
subsequent database search also allows
one to reduce the space [18].
False Discovery Rate (FDR) of
Spectral Identification
Due to the stochastic variation in the
spectra, deficiencies of the scoring
schemes, and possible incompleteness of
the database, only a fraction of best-
scoring PSMs are typically correct. There
is thus a need for a statistical measure of
‘‘confidence’’ in a reported list of PSMs,
and for an inferential procedure that
Figure 1. Example of spectral data. (A) LC-MS run. Features in the LC-MS space are peptide ions; their intensity is related to peptide abundance.
(B) MS/MS spectrum. The spectrum is obtained by fragmenting the peptide ion isolated from an LC-MS peak. The peaks are fragment ions; distances
between peaks are used for peptide sequence determination.
doi:10.1371/journal.pcbi.1000366.g001
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An accepted statistical measure is FDR,
defined as the expected proportion of
incorrect identifications in a list of PSMs
with scores above a cutoff. To determine
FDR-controlled lists of PSMs, the target–
decoy strategy [19] appends a randomized
versionofthetheoreticaldatabase(decoy)to
the actual database (target), and estimates
the FDR as twice the proportion of decoy
matches among all the matches in the list.
Alternatively, Peptide Prophet [20] fits an
Empirical Bayes two-group mixture model
to scores of correct and incorrect identifi-
cations, and estimates the FDR as the fitted
probability of correct identifications for
scores above a cutoff. Numerous extensions
are continually proposed (see, e.g., http://
pubs.acs.org/toc/jprobs/7/1), and in the
future the focus will likely broaden to the
FDR of peptides, proteins, and protein sites.
Protein Inference
Confidently identified peptides can be
grouped to infer the protein components
of the mixture. This is nontrivial due to
ambiguous mappings of peptides to pro-
teins, and to the insufficient discrimination
of some proteins by the identified peptides
[21]. Current approaches use characteris-
tics such as the number of mapped
peptides, protein length, and peptide
detectability [22] to identify proteins.
More research is needed to control the
FDR in the protein list.
Resources
Extensive spectral databases are public-
ly available, e.g., the Peptide Atlas at
http://www.peptideatlas.org, containing
millions of spectra from biological exper-
iments, and http://regis-web.systemsbiol-
ogy.net/PublicDatasets, containing spec-
tra from controlled protein mixtures.
Quantification
Quantitative proteomics monitors pep-
tide and protein abundance across samples
of multiple types. The goals are similar to
other high-throughput experiments such
as gene expression microarrays [23,24]. A
typical workflow (Figure 2) involves mul-
tiple steps [25].
Signal Processing
Quantitative workflows require signal
processing beyond spectral identification.
Features in the spectra must be located
and quantified, annotated when possible
with peptide sequences information, and
aligned across runs. A variety of tools have
been implemented [26]; they are specific
to label-free or labeling workflows, but all
output a list of detected features and their
abundances across samples.
Transformation, Normalization, and
Summarization
The biological effects are multiplicative
in nature, and a logarithm transform of
intensities is frequently recommended.
Feature intensities are further normalized
across runs, e.g., using quantile normali-
zation [27]. When multiple features are
observed within a sample for a same
peptide or protein, they are often summa-
rized in one number.
Learning
Statistical and machine learning tools
are then applied for (1) class comparison, e.g.,
determination of proteins that change in
abundance between healthy individuals
and individuals with disease; (2) class
discovery, e.g., unsupervised detection of
sample subgroups with homogeneous
Figure 2. Example of a proteomic workflow using database-based identification and label-free quantification. (A) Identification of MS/
MS spectra. Experimental spectra are compared to peptides in a database, and the best-scoring PSMs are reported while controlling the FDR. Protein
sequences are identified from the peptides. (B) Label-free quantification. Features in LC-MS runs (shown with circles) are located, quantified, and
aligned across runs. (C) LC-MS features are annotated with peptide sequences when identifications are available (shown with filled circles). The
annotations are used to optimize the alignment of features across runs. The list of quantified, identified, and aligned features is then subjected to
transformation, normalization, and summarization. (D) The list of features is used as input to machine learning, functional annotation, and data
integration steps.
doi:10.1371/journal.pcbi.1000366.g002
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prediction, e.g., a supervised prediction of
a disease status of a new sample based
on its protein abundance. Here analysis
issues are similar to, e.g., gene expression
microarrays, in that the features are
interdependent, and their number exceeds
the number of samples. An example from
this area of research is [28].
Functional Annotation
Database technologies connect the pro-
teins to their annotations, e.g., from Gene
Ontology, or from databases of disease.
The annotations can confirm the plausi-
bility of the identifications, and can enable
tests for over-represented functional cate-
gories in the protein list [29].
Data Integration
Recent studies combine proteomic mea-
surements with gene expression and me-
tabolomic profiles, and/or known bio-
chemical networks, with the general goal
of protein function determination [30]. A
number of tools facilitate these tasks,
which include proprietary databases Gen-
eGo and Ingenuity, and open-source
Cytoscape at http://www.cytoscape.org
and Bioconductor at http://www.biocon-
ductor.org.
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